Rochester Clinical Research has been at the forefront of COVID-19 vaccine research. We began our first COVID-19 vaccine trial in August 2020. Since then, RCR has taken on over 10 COVID-19 vaccine trials and is now embarking on COVID-19 vaccine booster research.

Rochester Clinical Research conducted clinical trials on 2 out of the 3 currently EUA COVID-19 vaccines.

Janssen (Johnson & Johnson)Pfizer
500 Rochester volunteers enrolled and dosed at RCR400 Rochester Volunteers enrolled and dosed at RCR

Rochester Clinical Research is committed to staying at the forefront of fighting this pandemic and continuing to research ways to mitigate the spread of COVID-19.

RCR currently has COVID-19 vaccine studies as well as COVID-19 vaccine booster studies. Learn more here.